# Eric Abbate

> Eric Abbate is a synthetic-biology scientist turned CEO who led Solar Biotech, a Virginia-based startup building solar-powered, water-neutral fermentation plants to make biodesigned cosmetics, food ingredients and bioelectronic components. A UC Berkeley-trained molecular and cell biologist, he ran high-throughput genome-engineering and analytical biochemistry teams at Inscripta and was corresponding author on a widely cited paper on optimizing strain engineering for industrial-scale production. He steered Solar Biotech from lab science toward a modular 'BioNodes' manufacturing model before the company entered Chapter 11 in 2024 with plans to sell its assets and reboot.

- **Role:** CEO at Solar Biotech (Pictor Biotech Inc.)
- **Organizations:** Solar Biotech, Inscripta, Novozymes
- **Nationality:** American
- **Education:** PhD, Molecular and Cell Biology, University of California, Berkeley
- **Known for:** Corresponding author on a widely read review optimizing the Design-Build-Test-Learn strain-engineering framework for industrial biomanufacturing, Led analytical biochemistry and high-throughput genome-engineering screening teams at Inscripta, Rose from Director of Technology Development to CEO at Solar Biotech

## Career timeline

- **1998-2003** — PhD in Molecular and Cell Biology, UC Berkeley
- **earlier career** — Worked at Novozymes in industrial enzymes / biotech
- **at Inscripta** — Staff Scientist, then Director of Analytical Biochemistry, leading high-throughput screening for genome-engineering applications in Pleasanton, CA
- **2023** — Corresponding author on 'Optimizing the strain engineering process for industrial-scale production of bio-based molecules' (J Ind Microbiol Biotechnol)
- **at Solar Biotech** — Director of Technology Development, then promoted to CEO
- **2023-08** — Solar Biotech raised a Series A (~$4M reported), part of $30M+ total funding
- **2024-06** — Solar Biotech, Inc. and Noblegen Inc. filed Chapter 11 bankruptcy in Delaware (Case 24-11402) with plans to sell assets and reboot

## Achievements

- Corresponding author on a widely read review optimizing the Design-Build-Test-Learn strain-engineering framework for industrial biomanufacturing
- Led analytical biochemistry and high-throughput genome-engineering screening teams at Inscripta
- Rose from Director of Technology Development to CEO at Solar Biotech
- Championed a modular, solar-powered, carbon- and water-neutral biomanufacturing model ('BioNodes')

## Latest updates

- **2024-06** — Solar Biotech filed for Chapter 11 bankruptcy in Delaware, citing difficult capital markets, the loss of a major client and pandemic effects, with plans to sell its assets and reboot.

## Links

- Website: https://solarbiotech.com
- LinkedIn: http://www.linkedin.com/in/eric-abbate-2438a314

---

Profile page: https://yespress.io/eric-abbate
Published by YesPress — https://yespress.io
Last updated: 2026-06-12